Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.30
+0.75 (7.11%)
At close: May 13, 2026, 4:00 PM EDT
11.30
0.00 (0.00%)
After-hours: May 13, 2026, 4:00 PM EDT
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $207.88 million as of May 13, 2026. Its market cap has increased by 162.41% in one year.
Market Cap
207.88M
Enterprise Value
205.43M
1-Year Change
162.41%
Ranking
Category
Stock Price
$11.30
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $207.88M, a decrease of -33.42%. That is a compound annual growth rate of -12.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 194.08M | 39.52% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediWound | 207.31M |
| Atrium Therapeutics | 203.87M |
| Corbus Pharmaceuticals Holdings | 202.73M |
| Humacyte | 202.04M |
| Karyopharm Therapeutics | 200.97M |
| Caribou Biosciences | 199.47M |
| Tiziana Life Sciences | 199.09M |
| Whitehawk Therapeutics | 193.76M |